ASX - By Stock
|
IIQ |
Re:
Ann: INOVIQ and Promega sign Global EXO-NET Agreement
|
|
ML173
|
22 |
6.9K |
0 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
22
|
6.9K
|
0
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: INOVIQ and Promega sign Global EXO-NET Agreement
|
|
ML173
|
22 |
6.9K |
1 |
16/04/24 |
16/04/24 |
ASX - By Stock
|
22
|
6.9K
|
1
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: INOVIQ and Promega sign Global EXO-NET Agreement
|
|
ML173
|
22 |
6.9K |
7 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
22
|
6.9K
|
7
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: INOVIQ expands exosome IP
|
|
ML173
|
33 |
11K |
1 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
33
|
11K
|
1
|
|
ASX - By Stock
|
NOR |
Re:
General Comments
|
|
ML173
|
7.9K |
1.0M |
0 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
7.9K
|
1.0M
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Change in substantial holding
|
|
ML173
|
3 |
1.2K |
1 |
25/03/24 |
25/03/24 |
ASX - By Stock
|
3
|
1.2K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
ML173
|
164 |
46K |
0 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
164
|
46K
|
0
|
|
ASX - By Stock
|
OEC |
Re:
Ann: Application for quotation of securities - OEC
|
|
ML173
|
1 |
815 |
0 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
1
|
815
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Change of Director's Interest Notice (DP)
|
|
ML173
|
21 |
4.9K |
2 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
21
|
4.9K
|
2
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Change of Director's Interest Notice (DP)
|
|
ML173
|
21 |
4.9K |
3 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
21
|
4.9K
|
3
|
|
ASX - By Stock
|
LOM |
Re:
Ann: Completion of Share Consolidation
|
|
ML173
|
12 |
2.6K |
0 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
12
|
2.6K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Change in substantial holding
|
|
ML173
|
5 |
1.2K |
0 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
5
|
1.2K
|
0
|
|
ASX - By Stock
|
PEN |
Re:
Ann: Ceasing to be a substantial holder from MUFG
|
|
ML173
|
4 |
1.3K |
0 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
4
|
1.3K
|
0
|
|
ASX - By Stock
|
OEC |
Re:
Ann: Appendix 4D & FY24 Half-Year Financial Report
|
|
ML173
|
6 |
2.9K |
0 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
6
|
2.9K
|
0
|
|
ASX - By Stock
|
OEC |
Re:
Ann: Appendix 4D & FY24 Half-Year Financial Report
|
|
ML173
|
6 |
2.9K |
1 |
09/03/24 |
09/03/24 |
ASX - By Stock
|
6
|
2.9K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
ML173
|
164 |
46K |
3 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
164
|
46K
|
3
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
ML173
|
164 |
46K |
5 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
164
|
46K
|
5
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
ML173
|
164 |
46K |
0 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
164
|
46K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Travelan to progress to Phase 3 Clinical Trials in the US
|
|
ML173
|
164 |
46K |
6 |
08/03/24 |
08/03/24 |
ASX - By Stock
|
164
|
46K
|
6
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Trading Halt
|
|
ML173
|
28 |
7.4K |
1 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
28
|
7.4K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Trading Halt
|
|
ML173
|
28 |
7.4K |
0 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
28
|
7.4K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Trading Halt
|
|
ML173
|
28 |
7.4K |
2 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
28
|
7.4K
|
2
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Trading Halt
|
|
ML173
|
28 |
7.4K |
0 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
28
|
7.4K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Trading Halt
|
|
ML173
|
28 |
7.4K |
0 |
07/03/24 |
07/03/24 |
ASX - By Stock
|
28
|
7.4K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Trading Halt
|
|
ML173
|
28 |
7.4K |
0 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
28
|
7.4K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Trading Halt
|
|
ML173
|
28 |
7.4K |
0 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
28
|
7.4K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Trading Halt
|
|
ML173
|
28 |
7.4K |
2 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
28
|
7.4K
|
2
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Trading Halt
|
|
ML173
|
28 |
7.4K |
0 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
28
|
7.4K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Trading Halt
|
|
ML173
|
28 |
7.4K |
1 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
28
|
7.4K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Appendix 4D and Half Year Report
|
|
ML173
|
12 |
3.1K |
0 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
12
|
3.1K
|
0
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Appendix 4D and Half Year Report
|
|
ML173
|
12 |
3.1K |
0 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
12
|
3.1K
|
0
|
|
ASX - By Stock
|
OEC |
Re:
Ann: Appendix 4D & FY24 Half-Year Financial Report
|
|
ML173
|
6 |
2.9K |
0 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
6
|
2.9K
|
0
|
|
ASX - By Stock
|
PEN |
Re:
Ann: Peninsula Strengthens Sales Contract Portfolio
|
|
ML173
|
45 |
17K |
2 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
45
|
17K
|
2
|
|
ASX - By Stock
|
OEC |
Re:
Ann: Appendix 4D & FY24 Half-Year Financial Report
|
|
ML173
|
6 |
2.9K |
2 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
6
|
2.9K
|
2
|
|
ASX - By Stock
|
PEN |
Re:
Ann: Peninsula Strengthens Sales Contract Portfolio
|
|
ML173
|
45 |
17K |
1 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
45
|
17K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Investor Webinar Presentation
|
|
ML173
|
5 |
2.0K |
1 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
5
|
2.0K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
Ann: Investor Webinar Presentation
|
|
ML173
|
5 |
2.0K |
0 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
5
|
2.0K
|
0
|
|
ASX - By Stock
|
MOB |
Re:
Ann: Public Filing of Form F-3 Shelf Registration Statement
|
|
ML173
|
10 |
1.2K |
2 |
11/10/23 |
11/10/23 |
ASX - By Stock
|
10
|
1.2K
|
2
|
|
ASX - By Stock
|
MOB |
Re:
Ann: Extension to Voluntary Delisting Date
|
|
ML173
|
19 |
2.5K |
0 |
10/10/23 |
10/10/23 |
ASX - By Stock
|
19
|
2.5K
|
0
|
|
ASX - By Stock
|
MOB |
Re:
Ann: MOB to trade exclusively on Nasdaq - Voluntary ASX delisting
|
|
ML173
|
121 |
17K |
1 |
05/10/23 |
05/10/23 |
ASX - By Stock
|
121
|
17K
|
1
|
|
ASX - By Stock
|
MOB |
Re:
Ann: MOB to trade exclusively on Nasdaq - Voluntary ASX delisting
|
|
ML173
|
121 |
17K |
1 |
04/10/23 |
04/10/23 |
ASX - By Stock
|
121
|
17K
|
1
|
|
ASX - By Stock
|
OEC |
Re:
Ann: Capital Raising and Leadership Update
|
|
ML173
|
5 |
2.2K |
5 |
26/09/23 |
26/09/23 |
ASX - By Stock
|
5
|
2.2K
|
5
|
|
ASX - By Stock
|
OEC |
Re:
Ann: Trading Halt
|
|
ML173
|
3 |
1.0K |
0 |
25/09/23 |
25/09/23 |
ASX - By Stock
|
3
|
1.0K
|
0
|
|
ASX - By Stock
|
MOB |
Re:
Ann: Change in substantial holding
|
|
ML173
|
6 |
818 |
0 |
25/09/23 |
25/09/23 |
ASX - By Stock
|
6
|
818
|
0
|
|
ASX - By Stock
|
OEC |
Re:
Ann: Trading Halt
|
|
ML173
|
3 |
1.0K |
1 |
22/09/23 |
22/09/23 |
ASX - By Stock
|
3
|
1.0K
|
1
|
|
ASX - By Stock
|
MOB |
Re:
Ann: MOB to trade exclusively on Nasdaq - Voluntary ASX delisting
|
|
ML173
|
121 |
17K |
2 |
19/09/23 |
19/09/23 |
ASX - By Stock
|
121
|
17K
|
2
|
|
ASX - By Stock
|
MOB |
Re:
Ann: MOB to trade exclusively on Nasdaq - Voluntary ASX delisting
|
|
ML173
|
121 |
17K |
1 |
18/09/23 |
18/09/23 |
ASX - By Stock
|
121
|
17K
|
1
|
|
ASX - By Stock
|
MOB |
Re:
Ann: MOB to trade exclusively on Nasdaq - Voluntary ASX delisting
|
|
ML173
|
121 |
17K |
1 |
11/09/23 |
11/09/23 |
ASX - By Stock
|
121
|
17K
|
1
|
|
ASX - By Stock
|
MOB |
Re:
Ann: MOB to trade exclusively on Nasdaq - Voluntary ASX delisting
|
|
ML173
|
121 |
17K |
1 |
11/09/23 |
11/09/23 |
ASX - By Stock
|
121
|
17K
|
1
|
|
ASX - By Stock
|
MOB |
Re:
Ann: MOB to trade exclusively on Nasdaq - Voluntary ASX delisting
|
|
ML173
|
121 |
17K |
2 |
11/09/23 |
11/09/23 |
ASX - By Stock
|
121
|
17K
|
2
|
|